ICC Labs reports investor approval of arrangement with Aurora Cannabis
ICC Labs Inc. announced that, at the special meeting of shareholders, shareholders overwhelmingly voted in favor of a special resolution to approve the previously announced plan of arrangement between ICC and Aurora Cannabis. Subject to the terms and conditions of an arrangement agreement between ICC and Aurora dated September 8, 2018, Aurora will acquire all of the issued and outstanding common shares of ICC . Obtaining approval from ICC Shareholders is one of the conditions to completing the Arrangement. Completion of the Arrangement remains subject to other customary closing conditions, including the aforementioned court order and the receipt of certain Uruguayan regulatory approvals. Assuming that the conditions to closing are satisfied or waived, it is expected that the Arrangement will be completed in the fourth quarter of 2018.